<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Dutasteride</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Dutasteride">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Dutasteride</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Dutasteride</b>, sold under the brand name <b>Avodart</b> among others, is a medication primarily used to treat the symptoms of an enlarged prostate.<span class="mw-ref" id="cite_ref-AHFS2019_4-0"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-BNF76_5-0"><a href="#cite_note-BNF76-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> A few months may be required before benefits occur.<span class="mw-ref" id="cite_ref-BNF76_5-1"><a href="#cite_note-BNF76-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is also used for scalp hair loss in men and as a part of hormone therapy in transgender women.<span class="mw-ref" id="cite_ref-ShapiroOtberg2015_6-0"><a href="#cite_note-ShapiroOtberg2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Trans2017_7-0"><a href="#cite_note-Trans2017-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_4-1"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Wu2013_8-0"><a href="#cite_note-Wu2013-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Dutasteride</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Dutasteride.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Dutasteride.svg.png" data-file-width="512" data-file-height="471" data-file-type="drawing" height="230" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Avodart, others; Combodart, Duodart (with <a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">tamsulosin</a>)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>GG-745; GI-198745; GI-198745X; <i>N</i>-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/dutasteride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/dutasteride.html'" tppabs="https://www.drugs.com/monograph/dutasteride.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a603001.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a603001.html'" tppabs="https://medlineplus.gov/druginfo/meds/a603001.html" class="external text external">a603001</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Dutasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Dutasteride'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Dutasteride" class="external text external">Dutasteride</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span></li></ul>

<ul><li>Not to be used during pregnancy</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>5α-Reductase inhibitor</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G04CB02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G04CB02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G04CB02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G04CB02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>60%<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-0"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>99%<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-1"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (CYP3A4)<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-2"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• 4'-Hydroxydutasteride<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-3"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>• 6'-Hydroxydutasteride<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-4"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>• 1,2-Dihydrodutasteride<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-5"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>(All three active)<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-6"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>4–5 weeks<span class="mw-ref" id="cite_ref-BurchumRosenthal2014_2-0"><a href="#cite_note-BurchumRosenthal2014-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Blu2008_3-0"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces: 40% (metabolites)<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-7"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>Urine: 5% (unchanged)<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-8"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(1S,3aS,3bS,5aR,9aR,9bS,11aS)-<i>N</i>-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=164656-23-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=164656-23-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=164656-23-9" class="external text external">164656-23-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/6918296  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/6918296'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/6918296" class="external text external">6918296</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7457  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7457'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7457" class="external text external">7457</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01126  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01126'" tppabs="https://www.drugbank.ca/drugs/DB01126" class="external text external">DB01126</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5293502.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5293502.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5293502.html" class="external text external">5293502</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=O0J6XJN02I  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=O0J6XJN02I'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=O0J6XJN02I" class="external text external">O0J6XJN02I</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D03820  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D03820'" tppabs="https://www.kegg.jp/entry/D03820" class="external text external">D03820</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:521033  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:521033'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:521033" class="external text external">CHEBI:521033</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1200969  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1200969'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1200969" class="external text external">ChEMBL1200969</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8046452  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8046452'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8046452" class="external text external">DTXSID8046452</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.166.372  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.166.372'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.166.372" class="external text external">100.166.372</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>27</sub><span>H</span><sub>30</sub><span>F</span><sub>6</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">528.539</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29%28F%29c1cc%28c%28cc1%29C%28F%29%28F%29F%29NC%28%3DO%29%5BC%40%40H%5D3%5BC%40%5D2%28CC%5BC%40H%5D4%5BC%40H%5D%28%5BC%40%40H%5D2CC3%29CC%5BC%40H%5D5NC%28%3DO%29%5CC%3DC%2F%5BC%40%5D45C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29%28F%29c1cc%28c%28cc1%29C%28F%29%28F%29F%29NC%28%3DO%29%5BC%40%40H%5D3%5BC%40%5D2%28CC%5BC%40H%5D4%5BC%40H%5D%28%5BC%40%40H%5D2CC3%29CC%5BC%40H%5D5NC%28%3DO%29%5CC%3DC%2F%5BC%40%5D45C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29%28F%29c1cc%28c%28cc1%29C%28F%29%28F%29F%29NC%28%3DO%29%5BC%40%40H%5D3%5BC%40%5D2%28CC%5BC%40H%5D4%5BC%40H%5D%28%5BC%40%40H%5D2CC3%29CC%5BC%40H%5D5NC%28%3DO%29%5CC%3DC%2F%5BC%40%5D45C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">FC(F)(F)c1cc(c(cc1)C(F)(F)F)NC(=O)[C@@H]3[C@]2(CC[C@H]4[C@H]([C@@H]2CC3)CC[C@H]5NC(=O)\C=C/[C@]45C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:JWJOTENAMICLJG-QWBYCMEYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461091686&page2=Dutasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461091686&page2=Dutasteride'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461091686&page2=Dutasteride" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include sexual problems, breast tenderness, and breast enlargement.<span class="mw-ref" id="cite_ref-AHFS2019_4-2"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Other side effects include an increased risk of certain forms of prostate cancer, depression, and angioedema.<span class="mw-ref" id="cite_ref-AHFS2019_4-3"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-BNF76_5-2"><a href="#cite_note-BNF76-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Exposure during pregnancy, including use by the partner of a pregnant women may result in harm to the baby.<span class="mw-ref" id="cite_ref-AHFS2019_4-4"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-BNF76_5-3"><a href="#cite_note-BNF76-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Dutasteride is a 5α-reductase inhibitor, and hence is a type of antiandrogen.<span class="mw-ref" id="cite_ref-Blu2008_3-1"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It works by decreasing the production of <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT), an androgen sex hormone.<span class="mw-ref" id="cite_ref-Agg2010_9-0"><a href="#cite_note-Agg2010-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2019_4-5"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<p>Dutasteride was patented in 1993 by GlaxoSmithKline and was approved for medical use in 2001.<span class="mw-ref" id="cite_ref-Fis2006_10-0"><a href="#cite_note-Fis2006-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2019_4-6"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-BNF76_5-4"><a href="#cite_note-BNF76-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> A month supply in the United Kingdom costs the NHS about £12  as of 2019.<span class="mw-ref" id="cite_ref-BNF76_5-5"><a href="#cite_note-BNF76-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> In the United States, the wholesale cost of this amount is about $6.66.<span class="mw-ref" id="cite_ref-NADAC2019_11-0"><a href="#cite_note-NADAC2019-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> In 2017, it was the 276th most commonly prescribed medication in the United States, with more than one million prescriptions.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Enlarged_prostate">Enlarged prostate</h3></summary>
    
<p>Dutasteride is used for treating benign prostatic hyperplasia (BPH); colloquially known as an "enlarged prostate".<span class="mw-ref" id="cite_ref-Wu2013_8-1"><a href="#cite_note-Wu2013-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It is approved by the Food and Drug Administration (FDA) in the U.S. for this indication.<span class="mw-ref" id="cite_ref-FDA_15-0"><a href="#cite_note-FDA-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Prostate_cancer">Prostate cancer</h3></summary>
    
<p>A 2010 Cochrane review found a 25–26% reduction in the risk of developing prostate cancer with 5α-reductase inhibitor chemoprevention.<span class="mw-ref" id="cite_ref-pmid20977593_16-0"><a href="#cite_note-pmid20977593-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> However, 5α-reductase inhibitors have been found to increase the risk of developing certain rare but aggressive forms of prostate cancer (27% risk increase), although not all studies have observed this.<span class="mw-ref" id="cite_ref-Hirs2016_17-0"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> There is insufficient data to determine if they have an effect on the overall risk of death from prostate cancer.<span class="mw-ref" id="cite_ref-Hirs2016_17-1"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Scalp_hair_loss">Scalp hair loss</h3></summary>
    
<p>Dutasteride is approved for the treatment of male androgenetic alopecia in South Korea and Japan at a dosage of 0.5<span>&nbsp;</span>mg per day.<span class="mw-ref" id="cite_ref-ShapiroOtberg2015_6-1"><a href="#cite_note-ShapiroOtberg2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid27489426_18-0"><a href="#cite_note-pmid27489426-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It has been found in several studies to improve hair growth in men more rapidly and to a greater extent than 2.5<span>&nbsp;</span>mg/day <a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">finasteride</a>.<span class="mw-ref" id="cite_ref-ShapiroOtberg2015_6-2"><a href="#cite_note-ShapiroOtberg2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The superior effectiveness of dutasteride relative to <a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">finasteride</a> for this indication is considered to be related to the fact that the inhibition of 5α-reductase and consequent prevention of scalp DHT production is more complete with dutasteride.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-9"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-TrüebLee2014_19-0"><a href="#cite_note-TrüebLee2014-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Dutasteride is also used off-label in the treatment of female pattern hair loss.<span class="mw-ref" id="cite_ref-pmid24017975_20-0"><a href="#cite_note-pmid24017975-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-CarminaAzziz2019_21-0"><a href="#cite_note-CarminaAzziz2019-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Excessive_hair_growth">Excessive hair growth</h3></summary>
    
<p>Although no reports specific to dutasteride currently exist,<span class="mw-ref" id="cite_ref-LebwohlHeymann2013_22-0"><a href="#cite_note-LebwohlHeymann2013-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-Blu2008_3-2"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> 5α-reductase inhibitors like finasteride have been found to be effective in the treatment of hirsutism (excessive facial and/or body hair growth) in women.<span class="mw-ref" id="cite_ref-Blu2008_3-3"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In a study of 89 women with hyperandrogenism due to persistent adrenarche syndrome, finasteride produced a 93% reduction in facial hirsutism and a 73% reduction in bodily hirsutism after 2 years of treatment.<span class="mw-ref" id="cite_ref-Blu2008_3-4"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Other studies using finasteride for hirsutism have also found it to be clearly effective.<span class="mw-ref" id="cite_ref-Blu2008_3-5"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Dutasteride may be more effective than finasteride for this indication due to the fact that its inhibition of the 5α-reductase enzyme is comparatively more complete.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-10"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Transgender_hormone_therapy">Transgender hormone therapy</h3></summary>
    
<p>Dutasteride is sometimes used as a component of hormone therapy for transgender women in combination with an estrogen and/or another antiandrogen like <a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">spironolactone</a>.<span class="mw-ref" id="cite_ref-Trans2017_7-1"><a href="#cite_note-Trans2017-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> It may be useful for treating scalp hair loss or in those who have issues tolerating spironolactone.<span class="mw-ref" id="cite_ref-Trans2017_7-2"><a href="#cite_note-Trans2017-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Dutasteride is provided in the form of soft oil-filled gelatin oral capsules containing 0.5<span>&nbsp;</span>mg dutasteride each.<span class="mw-ref" id="cite_ref-FDALabel_23-0"><a href="#cite_note-FDALabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Women who are or who may become pregnant should not handle the drug. Dutasteride can cause birth defects, specifically ambiguous genitalia and undermasculinization, in male fetuses.<span class="mw-ref" id="cite_ref-FDALabel_23-1"><a href="#cite_note-FDALabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-McVaryWelliver2016_24-0"><a href="#cite_note-McVaryWelliver2016-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> This is due to its antiandrogenic effects and is seen naturally in 5α-reductase deficiency.<span class="mw-ref" id="cite_ref-McVaryWelliver2016_24-1"><a href="#cite_note-McVaryWelliver2016-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> As such, women who are pregnant should never take dutasteride.<span class="mw-ref" id="cite_ref-FDALabel_23-2"><a href="#cite_note-FDALabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> People taking dutasteride should not donate blood to prevent birth defects if a pregnant women receives blood and, due to its long elimination half-life, should also not donate blood for at least 6<span>&nbsp;</span>months after the cessation of treatment.<span class="mw-ref" id="cite_ref-FDALabel_23-3"><a href="#cite_note-FDALabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>Children and people with known significant hypersensitivity (e.g., serious skin reactions, angioedema) to dutasteride should not take dutasteride.<span class="mw-ref" id="cite_ref-FDALabel_23-4"><a href="#cite_note-FDALabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Dutasteride has overall been found to be well tolerated in studies of both men and women, producing minimal side effects.<span class="mw-ref" id="cite_ref-Hirs2016_17-2"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Adverse effects include headache and gastrointestinal discomfort.<span class="mw-ref" id="cite_ref-Hirs2016_17-3"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Isolated reports of menstrual changes, acne, and dizziness also exist.<span class="mw-ref" id="cite_ref-Hirs2016_17-4"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> There is a small risk of gynecomastia (breast development or enlargement) in men.<span class="mw-ref" id="cite_ref-Hirs2016_17-5"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> The risk of gynecomastia with 5α-reductase inhibitors is about 2.8%.<span class="mw-ref" id="cite_ref-pmid27784557_25-0"><a href="#cite_note-pmid27784557-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>The FDA has added a warning to dutasteride about an increased risk of high-grade prostate cancer.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> While the potential for positive, negative or neutral changes to the potential risk of developing prostate cancer with dutasteride has not been established, evidence has suggested it may temporarily reduce the growth and prevalence of benign prostate tumors, but could also mask the early detection of prostate cancer. The primary area for concern is for patients who may develop prostate cancer whilst taking dutasteride for benign prostatic hyperplasia, which in turn could delay diagnosis and early treatment of the prostate cancer, thereby potentially increasing the risk of these patients developing high-grade prostate cancer.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> A 2018 meta-analysis found no higher risk of breast cancer with 5α-reductase inhibitors.<span class="mw-ref" id="cite_ref-pmid29697934_28-0"><a href="#cite_note-pmid29697934-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>

<p>Sexual dysfunction, such as erectile dysfunction, loss of libido, or reduced semen volume, may occur in 3.4 to 15.8% of men treated with finasteride or dutasteride.<span class="mw-ref" id="cite_ref-Hirs2016_17-6"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> This is linked to lower quality of life and can cause stress in relationships.<span class="mw-ref" id="cite_ref-Gur2013_30-0"><a href="#cite_note-Gur2013-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> It has been reported that in a subset of men, these adverse sexual side effects may persist even after discontinuation of finasteride or dutasteride.<span class="mw-ref" id="cite_ref-Tra2011_31-0"><a href="#cite_note-Tra2011-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Some have decreased sperm numbers as low as 10% of pretreatment values.<span class="mw-ref" id="cite_ref-DrobnisNangia2017_32-0"><a href="#cite_note-DrobnisNangia2017-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<p>Several small studies have reported an association between 5α-reductase inhibitors and depression.<span class="mw-ref" id="cite_ref-Hirs2016_17-7"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> However, most studies have not observed this side effect.<span class="mw-ref" id="cite_ref-Hirs2016_17-8"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> There have also been reports in a subset of men of long-lasting depression persisting even after discontinuation of dutasteride.<span class="mw-ref" id="cite_ref-Hirs2016_17-9"><a href="#cite_note-Hirs2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Tra2011_31-1"><a href="#cite_note-Tra2011-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>There is no specific antidote for overdose of dutasteride.<span class="mw-ref" id="cite_ref-Avodart-Label_33-0"><a href="#cite_note-Avodart-Label-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> Treatment of dutasteride overdose should be based on symptoms and should be supportive.<span class="mw-ref" id="cite_ref-Avodart-Label_33-1"><a href="#cite_note-Avodart-Label-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> The long elimination half-life of dutasteride should be taken into consideration in the event of an overdose of the medication.<span class="mw-ref" id="cite_ref-Avodart-Label_33-2"><a href="#cite_note-Avodart-Label-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> Dutasteride has been used in clinical studies at doses of up to 40<span>&nbsp;</span>mg/day for a week (80<span>&nbsp;</span>times the therapeutic dosage) and 5<span>&nbsp;</span>mg/day for 6<span>&nbsp;</span>months (10<span>&nbsp;</span>times the therapeutic dosage) with no significant safety concerns or additional side effects, respectively.<span class="mw-ref" id="cite_ref-Avodart-Label_33-3"><a href="#cite_note-Avodart-Label-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>5α-Reductase inhibitors can also prevent the formation of neurosteroid metabolites like <a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">allopregnanolone</a> from progesterone and hence may reduce or block the sedative, anticonvulsant, anxiolytic, and various other effects of progesterone, particularly in the case of oral progesterone (which is disproportionately converted into these metabolites due to first-pass metabolism).<span class="mw-ref" id="cite_ref-pmid26766596_34-0"><a href="#cite_note-pmid26766596-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid17924777_35-0"><a href="#cite_note-pmid17924777-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-Wang-ChengNeuner2007_36-0"><a href="#cite_note-Wang-ChengNeuner2007-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-BergemannRiecher-Rössler2005_37-0"><a href="#cite_note-BergemannRiecher-Rössler2005-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-pmid23978486_38-0"><a href="#cite_note-pmid23978486-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>Dutasteride belongs to a class of drugs called 5α-reductase inhibitors, which block the action of the 5α-reductase enzymes that convert testosterone into DHT.<span class="mw-ref" id="cite_ref-BostwickCheng2014_39-0"><a href="#cite_note-BostwickCheng2014-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> It inhibits all three forms of 5α-reductase, and can decrease DHT levels in the blood by up to 98%.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-11"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Yamana2010_40-0"><a href="#cite_note-Yamana2010-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-Bradbury2007_41-0"><a href="#cite_note-Bradbury2007-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Specifically it is a competitive, mechanism-based (irreversible) inhibitor of all three isoforms of 5α-reductase, types I, II, and III (<abbr>IC<sub>50</sub></abbr> values are 3.9<span>&nbsp;</span>nM for type I and 1.8<span>&nbsp;</span>nM for type II).<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-12"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Yamana2010_40-1"><a href="#cite_note-Yamana2010-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid18318566_42-0"><a href="#cite_note-pmid18318566-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-pmid9871428_43-0"><a href="#cite_note-pmid9871428-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> This is in contrast to finasteride, which is similarly an irreversible inhibitor of 5α-reductase<span class="mw-ref" id="cite_ref-pmid9871428_43-1"><a href="#cite_note-pmid9871428-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-KeserüSwinney2015_44-0"><a href="#cite_note-KeserüSwinney2015-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> but only inhibits the type II and III isoenzymes.<span class="mw-ref" id="cite_ref-Yamana2010_40-2"><a href="#cite_note-Yamana2010-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> As a result of this difference, dutasteride is able to achieve a reduction in circulating DHT levels of up to 98%, whereas finasteride is able to achieve a reduction of only 65 to 70%.<span class="mw-ref" id="cite_ref-Bradbury2007_41-1"><a href="#cite_note-Bradbury2007-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-BurchumRosenthal2014_2-1"><a href="#cite_note-BurchumRosenthal2014-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-BostwickCheng2014_39-1"><a href="#cite_note-BostwickCheng2014-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-HeesakkersChapple2016_45-0"><a href="#cite_note-HeesakkersChapple2016-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> In spite of the differential reduction in circulating DHT levels, the two drugs decrease levels of DHT to a similar extent of approximately 85 to 90% in the prostate gland,<span class="mw-ref" id="cite_ref-HeesakkersChapple2016_45-1"><a href="#cite_note-HeesakkersChapple2016-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> where the type II isoform of 5α-reductase predominates.<span class="mw-ref" id="cite_ref-pmid18318566_42-1"><a href="#cite_note-pmid18318566-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>Since 5α-reductases degrade testosterone to DHT, the inhibition of them could cause an increase in testosterone. However, a 2018 review found that initiation of 5α-reductase inhibitors did not result in a consistent increase in testosterone levels, with some studies showing increases and others showing no change.<span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> There was no statistically significant change in testosterone levels from 5α-reductase inhibitors in the overall meta-analysis, though men with lower baseline testosterone levels may a rise in testosterone levels.</p>

<p>In addition to inhibition of DHT production, 5α-reductase inhibitors like dutasteride are also neurosteroidogenesis inhibitors, preventing the 5α-reductase-mediated biosynthesis of various neurosteroids including <a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">allopregnanolone</a> (from <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>), <abbr>THDOC</abbr> (from deoxycorticosterone), and 3α-androstanediol (from testosterone).<span class="mw-ref" id="cite_ref-pmid24955220_47-0"><a href="#cite_note-pmid24955220-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> These neurosteroids are potent positive allosteric modulators of the GABA<sub>A</sub> receptor and have been found to possess antidepressant, anxiolytic, and pro-sexual effects in animal research.<span class="mw-ref" id="cite_ref-pmid24955220_47-1"><a href="#cite_note-pmid24955220-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-Weizman2008_48-0"><a href="#cite_note-Weizman2008-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-TvrdeićPoljak2016_49-0"><a href="#cite_note-TvrdeićPoljak2016-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> For this reason, prevention of neurosteroid formation may be involved in the sexual dysfunction and depression that has been associated with 5α-reductase inhibitors like dutasteride.<span class="mw-ref" id="cite_ref-pmid24955220_47-2"><a href="#cite_note-pmid24955220-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>The oral bioavailability of dutasteride is approximately 60%.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-13"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Food does not adversely affect the absorption of dutasteride.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-14"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Peak plasma levels occur 2 to 3<span>&nbsp;</span>hours after administration.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-15"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Levels of dutasteride in semen have been found to be 3<span>&nbsp;</span>ng/mL, with no significant effects on DHT levels in sexual partners.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-16"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The drug is extensively metabolized in the liver by CYP3A4.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-17"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It has three major metabolites, including 6'-hydroxydutasteride, 4'-hydroxydutasteride, and 1,2-dihydrodutasteride; the former two are formed by CYP3A4, while the latter is not.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-18"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> All three metabolites are active; 6'-hydroxydutasteride has similar potency as a 5α-reductase inhibitor to dutasteride, while the other two are less potent.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-19"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Dutasteride has an extremely long terminal or elimination half-life of about 4 or 5<span>&nbsp;</span>weeks.<span class="mw-ref" id="cite_ref-BurchumRosenthal2014_2-2"><a href="#cite_note-BurchumRosenthal2014-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Blu2008_3-6"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The elimination half-life of dutasteride is increased in the elderly (170<span>&nbsp;</span>hours for men age 20–49<span>&nbsp;</span>years, 300<span>&nbsp;</span>hours for men age &gt;70<span>&nbsp;</span>years).<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-20"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> No dosage adjustment is necessary in the elderly nor in renal impairment.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-21"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Because of its long elimination half-life, dutasteride remains in the body for a long time after discontinuation and can be detected for up to 4 to 6<span>&nbsp;</span>months.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-22"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-BurchumRosenthal2014_2-3"><a href="#cite_note-BurchumRosenthal2014-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In contrast to dutasteride, finasteride has a short terminal half-life of only 5 to 8<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-Blu2008_3-7"><a href="#cite_note-Blu2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-23"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Dutasteride is eliminated mainly in the feces (40%) as metabolites.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-24"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> A small portion (5%) is eliminated unchanged in the urine.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-25"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    


<p>Dutasteride, also known as <i>N</i>-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide, is a synthetic <a href="Androstane.htm" tppabs="https://ptable.com/wiki/compounds/A/Androstane" title="Androstane">androstane</a> steroid and a 4-azasteroid.<span class="mw-ref" id="cite_ref-LemkeWilliams2012_50-0"><a href="#cite_note-LemkeWilliams2012-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-Ravina2011_51-0"><a href="#cite_note-Ravina2011-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> It is an analogue of finasteride in which the <i>tert</i>-butyl amide moiety has been replaced with a 2,5-<i>bis</i>(trifluoromethyl)phenyl group.<span class="mw-ref" id="cite_ref-Ravina2011_51-1"><a href="#cite_note-Ravina2011-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Dutasteride was patented in 1996<span class="mw-ref" id="cite_ref-Drugs.com_52-0"><a href="#cite_note-Drugs.com-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> and was first described in the scientific literature in 1997.<span class="mw-ref" id="cite_ref-Llewellyn2011_53-0"><a href="#cite_note-Llewellyn2011-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> It was approved by the FDA for the treatment of BPH in November 2001 and was introduced into the United States market the following year under the brand name Avodart.<span class="mw-ref" id="cite_ref-Llewellyn2011_53-1"><a href="#cite_note-Llewellyn2011-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Dutasteride has subsequently been introduced in many other countries, including throughout Europe and South America.<span class="mw-ref" id="cite_ref-Llewellyn2011_53-2"><a href="#cite_note-Llewellyn2011-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> The patent protection of dutasteride expired in November 2015 and the drug has since become available in the United States in a variety of low-cost generic formulations.<span class="mw-ref" id="cite_ref-Drugs.com_52-1"><a href="#cite_note-Drugs.com-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>

<p>It was approved for the treatment of scalp hair loss in South Korea since 2009 and in Japan since 2015.<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> It has not been approved for this indication in the United States,<span class="mw-ref" id="cite_ref-ShapiroOtberg2015_6-3"><a href="#cite_note-ShapiroOtberg2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid27489426_18-1"><a href="#cite_note-pmid27489426-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> though it is often used off-label.<span class="mw-ref" id="cite_ref-pmid24017975_20-1"><a href="#cite_note-pmid24017975-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:202px"><img src="../I/m/Avodart.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Avodart.jpg" data-file-width="2914" data-file-height="2887" data-file-type="bitmap" height="198" width="200"><div class="thumbcaption" style="text-align: left">Avodart (dutasteride) 500 µg soft capsules.</div></div></div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p><i>Dutasteride</i> is the generic name of the drug and its <abbr>INN</abbr>, <abbr>USAN</abbr>, <abbr>BAN</abbr>, and <abbr>JAN</abbr>.<span class="mw-ref" id="cite_ref-Drugs.com-2_55-0"><a href="#cite_note-Drugs.com-2-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Dutasteride is sold primarily under the brand name Avodart and, in combination with <a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">tamsulosin</a> (see dutasteride/tamsulosin), under the brand names Combodart and Duodart.<span class="mw-ref" id="cite_ref-Drugs.com-2_55-1"><a href="#cite_note-Drugs.com-2-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> It is also sold under a variety of generic brand names.<span class="mw-ref" id="cite_ref-Drugs.com-2_55-2"><a href="#cite_note-Drugs.com-2-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> Dutasteride is also available in combination with <a href="Alfuzosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfuzosin" title="Alfuzosin">alfuzosin</a> under the brand names Alfusin-D and Dutalfa, but only in India.<span class="mw-ref" id="cite_ref-Drugs.com-2_55-3"><a href="#cite_note-Drugs.com-2-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    
<p>Dutasteride is available widely throughout the world, including in the United States, Canada, the United Kingdom, Ireland, many other European countries, Australia, and South Africa, as well as in Latin America, Asia, and elsewhere.<span class="mw-ref" id="cite_ref-Drugs.com-2_55-4"><a href="#cite_note-Drugs.com-2-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> It is available as a generic medication in the United States and other countries.<span class="mw-ref" id="cite_ref-Drugs.com_52-2"><a href="#cite_note-Drugs.com-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Dutasteride has been studied in combination with <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a> in the treatment of prostate cancer.<span class="mw-ref" id="cite_ref-pmid16844453_56-0"><a href="#cite_note-pmid16844453-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-pmid19796455_57-0"><a href="#cite_note-pmid19796455-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-pmid26048455_58-0"><a href="#cite_note-pmid26048455-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-pmid26702991_59-0"><a href="#cite_note-pmid26702991-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-pmid27330919_60-0"><a href="#cite_note-pmid27330919-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> A study found that dutasteride, which blocks the formation of the neurosteroid allopregnanolone from progesterone, is effective in reducing symptoms in women with premenstrual dysphoric disorder.<span class="mw-ref" id="cite_ref-pmid26766596_34-1"><a href="#cite_note-pmid26766596-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-LemkeWilliams2008-1"> <span id="mw-reference-text-cite_note-LemkeWilliams2008-1" class="mw-reference-text"><cite id="CITEREFThomas_L._LemkeDavid_A._Williams2008" class="citation book cs1">Thomas L. Lemke; David A. Williams (2008). <a href="javascript:if(confirm('https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA1286  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA1286'" tppabs="https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA1286" class="external text external"><i>Foye's Principles of Medicinal Chemistry</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>1286–1287. ISBN<span>&nbsp;</span><bdi>978-0-7817-6879-5</bdi>.</cite></span></li><li id="cite_note-BurchumRosenthal2014-2"> <span id="mw-reference-text-cite_note-BurchumRosenthal2014-2" class="mw-reference-text"><cite id="CITEREFJacqueline_BurchumLaura_Rosenthal2014" class="citation book cs1">Jacqueline Burchum; Laura Rosenthal (2 December 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=C7_NBQAAQBAJ&pg=PA803  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=C7_NBQAAQBAJ&pg=PA803'" tppabs="https://books.google.com/books?id=C7_NBQAAQBAJ&pg=PA803" class="external text external"><i>Lehne's Pharmacology for Nursing Care</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>803–. ISBN<span>&nbsp;</span><bdi>978-0-323-34026-7</bdi>.</cite></span></li><li id="cite_note-Blu2008-3"> <span id="mw-reference-text-cite_note-Blu2008-3" class="mw-reference-text"><cite id="CITEREFUlrike_Blume-PeytaviDavid_A._WhitingRalph_M._Trüeb2008" class="citation book cs1">Ulrike Blume-Peytavi; David A. Whiting; Ralph M. Trüeb (26 June 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=pHrX2-huQCoC&pg=PA369  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=pHrX2-huQCoC&pg=PA369'" tppabs="https://books.google.com/books?id=pHrX2-huQCoC&pg=PA369" class="external text external"><i>Hair Growth and Disorders</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>182, 369. ISBN<span>&nbsp;</span><bdi>978-3-540-46911-7</bdi>.</cite></span></li><li id="cite_note-AHFS2019-4"> <span id="mw-reference-text-cite_note-AHFS2019-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/dutasteride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/dutasteride.html'" tppabs="https://www.drugs.com/monograph/dutasteride.html" class="external text external">"Dutasteride Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">18 March</span> 2019</span>.</cite></span></li><li id="cite_note-BNF76-5"> <span id="mw-reference-text-cite_note-BNF76-5" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. p.<span>&nbsp;</span>769. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-ShapiroOtberg2015-6"> <span id="mw-reference-text-cite_note-ShapiroOtberg2015-6" class="mw-reference-text"><cite id="CITEREFJerry_ShapiroNina_Otberg2015" class="citation book cs1">Jerry Shapiro; Nina Otberg (17 April 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=bJG9BwAAQBAJ&pg=PA39  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=bJG9BwAAQBAJ&pg=PA39'" tppabs="https://books.google.com/books?id=bJG9BwAAQBAJ&pg=PA39" class="external text external"><i>Hair Loss and Restoration, Second Edition</i></a>. CRC Press. pp.<span>&nbsp;</span>39–. ISBN<span>&nbsp;</span><bdi>978-1-4822-3199-1</bdi>.</cite></span></li><li id="cite_note-Trans2017-7"> <span id="mw-reference-text-cite_note-Trans2017-7" class="mw-reference-text"><cite id="CITEREFWespDeutsch2017" class="citation journal cs1">Wesp LM, Deutsch MB (2017). "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". <i>Psychiatr. Clin. North Am</i>. <b>40</b> (1): 99–111. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.psc.2016.10.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.psc.2016.10.006'" tppabs="https://doi.org/10.1016%2Fj.psc.2016.10.006" class="external text external">10.1016/j.psc.2016.10.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28159148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28159148'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28159148" class="external text external">28159148</a>.</cite></span></li><li id="cite_note-Wu2013-8"> <span id="mw-reference-text-cite_note-Wu2013-8" class="mw-reference-text"><cite id="CITEREFWuKapoor2013" class="citation journal cs1">Wu C, Kapoor A (2013). "Dutasteride for the treatment of benign prostatic hyperplasia". <i>Expert Opin Pharmacother</i>. <b>14</b> (10): 1399–408. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2013.797965  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2013.797965'" tppabs="https://doi.org/10.1517%2F14656566.2013.797965" class="external text external">10.1517/14656566.2013.797965</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23750593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23750593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23750593" class="external text external">23750593</a>.</cite></span></li><li id="cite_note-Agg2010-9"> <span id="mw-reference-text-cite_note-Agg2010-9" class="mw-reference-text"><cite id="CITEREFAggarwalTharejaVermaBhardwaj2010" class="citation journal cs1">Aggarwal S, Thareja S, Verma A, Bhardwaj TR, Kumar M (February 2010). "An overview on 5alpha-reductase inhibitors". <i>Steroids</i>. <b>75</b> (2): 109–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.steroids.2009.10.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.steroids.2009.10.005'" tppabs="https://doi.org/10.1016%2Fj.steroids.2009.10.005" class="external text external">10.1016/j.steroids.2009.10.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19879888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19879888'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19879888" class="external text external">19879888</a>.</cite></span></li><li id="cite_note-Fis2006-10"> <span id="mw-reference-text-cite_note-Fis2006-10" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA483'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA483" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>483. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-NADAC2019-11"> <span id="mw-reference-text-cite_note-NADAC2019-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6" class="external text external">"NADAC as of 2019-02-27"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Dutasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Dutasteride'" tppabs="https://clincalc.com/DrugStats/Drugs/Dutasteride" class="external text external">"Dutasteride - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFSlaterDumas,_CBubley,_G2012" class="citation journal cs1">Slater, S; Dumas, C; Bubley, G (March 2012). "Dutasteride for the treatment of prostate-related conditions". <i>Expert Opinion on Drug Safety</i>. <b>11</b> (2): 325–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2012.658040  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2012.658040'" tppabs="https://doi.org/10.1517%2F14740338.2012.658040" class="external text external">10.1517/14740338.2012.658040</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22316171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22316171'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22316171" class="external text external">22316171</a>.</cite></span></li><li id="cite_note-FDA-15"> <span id="mw-reference-text-cite_note-FDA-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&ApplNo=021319&DrugName=AVODART&ActiveIngred=DUTASTERIDE&SponsorApplicant=GLAXOSMITHKLINE&ProductMktStatus=1&goto=Search.DrugDetails  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&ApplNo=021319&DrugName=AVODART&ActiveIngred=DUTASTERIDE&SponsorApplicant=GLAXOSMITHKLINE&ProductMktStatus=1&goto=Search.DrugDetails'" tppabs="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&ApplNo=021319&DrugName=AVODART&ActiveIngred=DUTASTERIDE&SponsorApplicant=GLAXOSMITHKLINE&ProductMktStatus=1&goto=Search.DrugDetails" class="external text external">"Drugs@FDA: FDA Approved Drug Products"</a>. <i>www.accessdata.fda.gov</i>.</cite></span></li><li id="cite_note-pmid20977593-16"> <span id="mw-reference-text-cite_note-pmid20977593-16" class="mw-reference-text"><cite id="CITEREFWiltMacdonaldHagertySchellhammer2010" class="citation journal cs1">Wilt TJ, Macdonald R, Hagerty K, Schellhammer P, Tacklind J, Somerfield MR, Kramer BS (2010). "5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review". <i>BJU Int</i>. <b>106</b> (10): 1444–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410X.2010.09714.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410X.2010.09714.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410X.2010.09714.x" class="external text external">10.1111/j.1464-410X.2010.09714.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20977593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20977593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20977593" class="external text external">20977593</a>.</cite></span></li><li id="cite_note-Hirs2016-17"> <span id="mw-reference-text-cite_note-Hirs2016-17" class="mw-reference-text"><cite id="CITEREFHirshburgKelseyTherrienGavino2016" class="citation journal cs1">Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004" class="external text external">"Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review"</a>. <i>J Clin Aesthet Dermatol</i>. <b>9</b> (7): 56–62. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004" class="external text external">5023004</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27672412  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27672412'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27672412" class="external text external">27672412</a>.</cite></span></li><li id="cite_note-pmid27489426-18"> <span id="mw-reference-text-cite_note-pmid27489426-18" class="mw-reference-text"><cite id="CITEREFChoiKimOhPark2016" class="citation journal cs1">Choi GS, Kim JH, Oh SY, Park JM, Hong JS, Lee YS, Lee WS (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473" class="external text external">"Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia"</a>. <i>Ann Dermatol</i>. <b>28</b> (4): 444–50. doi:<a href="javascript:if(confirm('https://doi.org/10.5021%2Fad.2016.28.4.444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5021%2Fad.2016.28.4.444'" tppabs="https://doi.org/10.5021%2Fad.2016.28.4.444" class="external text external">10.5021/ad.2016.28.4.444</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473" class="external text external">4969473</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27489426  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27489426'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27489426" class="external text external">27489426</a>.</cite></span></li><li id="cite_note-TrüebLee2014-19"> <span id="mw-reference-text-cite_note-TrüebLee2014-19" class="mw-reference-text"><cite id="CITEREFRalph_M._TrüebWon-Soo_Lee2014" class="citation book cs1">Ralph M. Trüeb; Won-Soo Lee (13 February 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0ue5BAAAQBAJ&pg=PA91  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0ue5BAAAQBAJ&pg=PA91'" tppabs="https://books.google.com/books?id=0ue5BAAAQBAJ&pg=PA91" class="external text external"><i>Male Alopecia: Guide to Successful Management</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>91–. ISBN<span>&nbsp;</span><bdi>978-3-319-03233-7</bdi>.</cite></span></li><li id="cite_note-pmid24017975-20"> <span id="mw-reference-text-cite_note-pmid24017975-20" class="mw-reference-text"><cite id="CITEREFNusbaumRoseNusbaum2013" class="citation journal cs1">Nusbaum AG, Rose PT, Nusbaum BP (2013). "Nonsurgical therapy for hair loss". <i>Facial Plast Surg Clin North Am</i>. <b>21</b> (3): 335–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.fsc.2013.04.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.fsc.2013.04.003'" tppabs="https://doi.org/10.1016%2Fj.fsc.2013.04.003" class="external text external">10.1016/j.fsc.2013.04.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24017975  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24017975'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24017975" class="external text external">24017975</a>.</cite></span></li><li id="cite_note-CarminaAzziz2019-21"> <span id="mw-reference-text-cite_note-CarminaAzziz2019-21" class="mw-reference-text"><cite id="CITEREFCarminaAzzizBergfeldEscobar-Morreale2019" class="citation journal cs1">Carmina, Enrico; Azziz, Ricardo; Bergfeld, Wilma; Escobar-Morreale, Héctor F; Futterweit, Walter; Huddleston, Heather; Lobo, Rogerio; Olsen, Elise (2019). "Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee". <i>The Journal of Clinical Endocrinology &amp; Metabolism</i>. <b>104</b> (7): 2875–2891. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjc.2018-02548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjc.2018-02548'" tppabs="https://doi.org/10.1210%2Fjc.2018-02548" class="external text external">10.1210/jc.2018-02548</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0021-972X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0021-972X'" tppabs="https://www.worldcat.org/issn/0021-972X" class="external text external">0021-972X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30785992  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30785992'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30785992" class="external text external">30785992</a>.</cite></span></li><li id="cite_note-LebwohlHeymann2013-22"> <span id="mw-reference-text-cite_note-LebwohlHeymann2013-22" class="mw-reference-text"><cite id="CITEREFMark_G._LebwohlWarren_R._HeymannJohn_Berth-JonesIan_Coulson2013" class="citation book cs1">Mark G. Lebwohl; Warren R. Heymann; John Berth-Jones; Ian Coulson (19 September 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=hRryAAAAQBAJ&pg=PA327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=hRryAAAAQBAJ&pg=PA327'" tppabs="https://books.google.com/books?id=hRryAAAAQBAJ&pg=PA327" class="external text external"><i>Treatment of Skin Disease: Comprehensive Therapeutic Strategies</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>327–. ISBN<span>&nbsp;</span><bdi>978-0-7020-5236-1</bdi>.</cite></span></li><li id="cite_note-FDALabel-23"> <span id="mw-reference-text-cite_note-FDALabel-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf" class="external text external">"FDA prescribing information"</a> <span class="cs1-format">(PDF)</span>. June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">15 September</span> 2013</span>.</cite></span></li><li id="cite_note-McVaryWelliver2016-24"> <span id="mw-reference-text-cite_note-McVaryWelliver2016-24" class="mw-reference-text"><cite id="CITEREFKevin_T._McVaryCharles_Welliver2016" class="citation book cs1">Kevin T. McVary; Charles Welliver (12 August 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=OkLUDAAAQBAJ&pg=PA396  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=OkLUDAAAQBAJ&pg=PA396'" tppabs="https://books.google.com/books?id=OkLUDAAAQBAJ&pg=PA396" class="external text external"><i>Treatment of Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Current methods, outcomes, and controversies, An Issue of Urologic Clinics of North America, E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>396–. ISBN<span>&nbsp;</span><bdi>978-0-323-45994-5</bdi>.</cite></span></li><li id="cite_note-pmid27784557-25"> <span id="mw-reference-text-cite_note-pmid27784557-25" class="mw-reference-text"><cite id="CITEREFTrostSaitzHellstrom2013" class="citation journal cs1">Trost L, Saitz TR, Hellstrom WJ (2013). "Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review". <i>Sex Med Rev</i>. <b>1</b> (1): 24–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fsmrj.3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fsmrj.3'" tppabs="https://doi.org/10.1002%2Fsmrj.3" class="external text external">10.1002/smrj.3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27784557  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27784557'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27784557" class="external text external">27784557</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm'" tppabs="https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm" class="external text external">"5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer - U.S. Department of Health &amp; Human Services"</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFWalsh2010" class="citation journal cs1">Walsh, PC (Apr 1, 2010). "Chemoprevention of prostate cancer". <i>The New England Journal of Medicine</i>. <b>362</b> (13): 1237–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMe1001045  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMe1001045'" tppabs="https://doi.org/10.1056%2FNEJMe1001045" class="external text external">10.1056/NEJMe1001045</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20357287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20357287'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20357287" class="external text external">20357287</a>.</cite></span></li><li id="cite_note-pmid29697934-28"> <span id="mw-reference-text-cite_note-pmid29697934-28" class="mw-reference-text"><cite id="CITEREFWangZhaoLuoLi2018" class="citation journal cs1">Wang J, Zhao S, Luo L, Li E, Li X, Zhao Z (2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523" class="external text external">"5-alpha Reductase Inhibitors and risk of male breast cancer: a systematic review and meta-analysis"</a>. <i>Int Braz J Urol</i>. <b>44</b> (5): 865–873. doi:<a href="javascript:if(confirm('https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531'" tppabs="https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531" class="external text external">10.1590/S1677-5538.IBJU.2017.0531</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523" class="external text external">6237523</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29697934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29697934'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29697934" class="external text external">29697934</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFLiuZhaoLiLi2016" class="citation journal cs1">Liu, L; Zhao, S; Li, F; Li, E; Kang, R; Luo, L; Luo, J; Wan, S; Zhao, Z (September 2016). "Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials". <i>The Journal of Sexual Medicine</i>. <b>13</b> (9): 1297–310. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jsxm.2016.07.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jsxm.2016.07.006'" tppabs="https://doi.org/10.1016%2Fj.jsxm.2016.07.006" class="external text external">10.1016/j.jsxm.2016.07.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27475241  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27475241'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27475241" class="external text external">27475241</a>.</cite></span></li><li id="cite_note-Gur2013-30"> <span id="mw-reference-text-cite_note-Gur2013-30" class="mw-reference-text"><cite id="CITEREFGurKadowitz,_PJHellstrom,_WJ2013" class="citation journal cs1">Gur, S; Kadowitz, PJ; Hellstrom, WJ (January 2013). "Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation". <i>Expert Opinion on Drug Safety</i>. <b>12</b> (1): 81–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2013.742885  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2013.742885'" tppabs="https://doi.org/10.1517%2F14740338.2013.742885" class="external text external">10.1517/14740338.2013.742885</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23173718  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23173718'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23173718" class="external text external">23173718</a>.</cite></span></li><li id="cite_note-Tra2011-31"> <span id="mw-reference-text-cite_note-Tra2011-31" class="mw-reference-text"><cite id="CITEREFTraishHassani,_JGuay,_ATZitzmann,_M2011" class="citation journal cs1">Traish, AM; Hassani, J; Guay, AT; Zitzmann, M; Hansen, ML (March 2011). "Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients". <i>The Journal of Sexual Medicine</i>. <b>8</b> (3): 872–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1743-6109.2010.02157.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1743-6109.2010.02157.x'" tppabs="https://doi.org/10.1111%2Fj.1743-6109.2010.02157.x" class="external text external">10.1111/j.1743-6109.2010.02157.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21176115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21176115'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21176115" class="external text external">21176115</a>.</cite></span></li><li id="cite_note-DrobnisNangia2017-32"> <span id="mw-reference-text-cite_note-DrobnisNangia2017-32" class="mw-reference-text"><cite id="CITEREFDrobnisNangia2017" class="citation book cs1">Drobnis, Erma Z.; Nangia, Ajay K. (2017). <i>Impacts of Medications on Male Fertility</i>. Advances in Experimental Medicine and Biology. <b>1034</b>. pp.<span>&nbsp;</span>59–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-319-69535-8_7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-319-69535-8_7'" tppabs="https://doi.org/10.1007%2F978-3-319-69535-8_7" class="external text external">10.1007/978-3-319-69535-8_7</a>. ISBN<span>&nbsp;</span><bdi>978-3-319-69534-1</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0065-2598  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0065-2598'" tppabs="https://www.worldcat.org/issn/0065-2598" class="external text external">0065-2598</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29256127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29256127'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29256127" class="external text external">29256127</a>.</cite></span></li><li id="cite_note-Avodart-Label-33"> <span id="mw-reference-text-cite_note-Avodart-Label-33" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf" class="external text external">"Prescribing information"</a> <span class="cs1-format">(PDF)</span>. <i>www.accessdata.fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-01-10</span></span>.</cite></span></li><li id="cite_note-pmid26766596-34"> <span id="mw-reference-text-cite_note-pmid26766596-34" class="mw-reference-text"><cite id="CITEREFPearlstein2016" class="citation journal cs1">Pearlstein T (2016). <a href="javascript:if(confirm('https://doi.org/10.1586/17512433.2016.1142371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586/17512433.2016.1142371'" tppabs="https://doi.org/10.1586/17512433.2016.1142371" class="external text external">"Treatment of Premenstrual Dysphoric Disorder: Therapeutic Challenges"</a>. <i>Expert Rev Clin Pharmacol</i>. <b>9</b> (4): 1–4. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1586%2F17512433.2016.1142371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F17512433.2016.1142371'" tppabs="https://doi.org/10.1586%2F17512433.2016.1142371" class="external text external">10.1586/17512433.2016.1142371</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26766596  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26766596'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26766596" class="external text external">26766596</a>. <q>A recent study with a 5α-reductase inhibitor dutasteride, that blocks the conversion of progesterone to ALLO, reported that dutasteride 2.5 mg daily decreased several premenstrual symptoms [7].</q></cite></span></li><li id="cite_note-pmid17924777-35"> <span id="mw-reference-text-cite_note-pmid17924777-35" class="mw-reference-text"><cite id="CITEREFGoletianiKeithGorsky2007" class="citation journal cs1">Goletiani NV, Keith DR, Gorsky SJ (2007). "Progesterone: review of safety for clinical studies". <i>Exp Clin Psychopharmacol</i>. <b>15</b> (5): 427–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1037%2F1064-1297.15.5.427  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1037%2F1064-1297.15.5.427'" tppabs="https://doi.org/10.1037%2F1064-1297.15.5.427" class="external text external">10.1037/1064-1297.15.5.427</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17924777  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17924777'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17924777" class="external text external">17924777</a>.</cite></span></li><li id="cite_note-Wang-ChengNeuner2007-36"> <span id="mw-reference-text-cite_note-Wang-ChengNeuner2007-36" class="mw-reference-text"><cite id="CITEREFWang-ChengNeunerBarnabei2007" class="citation book cs1">Wang-Cheng R, Neuner JM, Barnabei VM (2007). <a href="javascript:if(confirm('https://books.google.com/books?id=mPs5Ly71OCQC&pg=PA97  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=mPs5Ly71OCQC&pg=PA97'" tppabs="https://books.google.com/books?id=mPs5Ly71OCQC&pg=PA97" class="external text external"><i>Menopause</i></a>. ACP Press. p.<span>&nbsp;</span>97. ISBN<span>&nbsp;</span><bdi>978-1-930513-83-9</bdi>.</cite></span></li><li id="cite_note-BergemannRiecher-Rössler2005-37"> <span id="mw-reference-text-cite_note-BergemannRiecher-Rössler2005-37" class="mw-reference-text"><cite id="CITEREFBergemannAriecher-Rössler2005" class="citation book cs1">Bergemann N, Ariecher-Rössler A (27 December 2005). <a href="javascript:if(confirm('https://books.google.com/books?id=L4YQ50SbBnsC&pg=PA179  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=L4YQ50SbBnsC&pg=PA179'" tppabs="https://books.google.com/books?id=L4YQ50SbBnsC&pg=PA179" class="external text external"><i>Estrogen Effects in Psychiatric Disorders</i></a>. Springer Science &amp; Business Media. p.<span>&nbsp;</span>179. ISBN<span>&nbsp;</span><bdi>978-3-211-27063-9</bdi>.</cite></span></li><li id="cite_note-pmid23978486-38"> <span id="mw-reference-text-cite_note-pmid23978486-38" class="mw-reference-text"><cite id="CITEREFBäckströmBixoJohanssonNyberg2014" class="citation journal cs1">Bäckström T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, Savic I, Strömberg J, Timby E, van Broekhoven F, van Wingen G (2014). "Allopregnanolone and mood disorders". <i>Prog. Neurobiol</i>. <b>113</b>: 88–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pneurobio.2013.07.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pneurobio.2013.07.005'" tppabs="https://doi.org/10.1016%2Fj.pneurobio.2013.07.005" class="external text external">10.1016/j.pneurobio.2013.07.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23978486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23978486'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23978486" class="external text external">23978486</a>.</cite></span></li><li id="cite_note-BostwickCheng2014-39"> <span id="mw-reference-text-cite_note-BostwickCheng2014-39" class="mw-reference-text"><cite id="CITEREFDavid_G._BostwickLiang_Cheng2014" class="citation book cs1">David G. Bostwick; Liang Cheng (24 January 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=wrHQAgAAQBAJ&pg=PA492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=wrHQAgAAQBAJ&pg=PA492'" tppabs="https://books.google.com/books?id=wrHQAgAAQBAJ&pg=PA492" class="external text external"><i>Urologic Surgical Pathology</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>492–. ISBN<span>&nbsp;</span><bdi>978-0-323-08619-6</bdi>.</cite></span></li><li id="cite_note-Yamana2010-40"> <span id="mw-reference-text-cite_note-Yamana2010-40" class="mw-reference-text"><cite id="CITEREFYamanaLabrieLuu-The2010" class="citation journal cs1">Yamana K, Labrie F, Luu-The V (January 2010). "Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". <i>Hormone Molecular Biology and Clinical Investigation</i>. <b>2</b> (3): 293–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2Fhmbci.2010.035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2Fhmbci.2010.035'" tppabs="https://doi.org/10.1515%2Fhmbci.2010.035" class="external text external">10.1515/hmbci.2010.035</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25961201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25961201'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25961201" class="external text external">25961201</a>.</cite></span></li><li id="cite_note-Bradbury2007-41"> <span id="mw-reference-text-cite_note-Bradbury2007-41" class="mw-reference-text"><cite id="CITEREFRob_Bradbury2007" class="citation book cs1">Rob Bradbury (30 January 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=fdtDAAAAQBAJ&pg=PA49  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=fdtDAAAAQBAJ&pg=PA49'" tppabs="https://books.google.com/books?id=fdtDAAAAQBAJ&pg=PA49" class="external text external"><i>Cancer</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>49–. ISBN<span>&nbsp;</span><bdi>978-3-540-33120-9</bdi>.</cite></span></li><li id="cite_note-pmid18318566-42"> <span id="mw-reference-text-cite_note-pmid18318566-42" class="mw-reference-text"><cite id="CITEREFKeamScott2008" class="citation journal cs1">Keam SJ, Scott LJ (2008). "Dutasteride: a review of its use in the management of prostate disorders". <i>Drugs</i>. <b>68</b> (4): 463–85. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200868040-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200868040-00008'" tppabs="https://doi.org/10.2165%2F00003495-200868040-00008" class="external text external">10.2165/00003495-200868040-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18318566  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18318566'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18318566" class="external text external">18318566</a>.</cite></span></li><li id="cite_note-pmid9871428-43"> <span id="mw-reference-text-cite_note-pmid9871428-43" class="mw-reference-text"><cite id="CITEREFGisleskogHermannHammarlund-UdenaesKarlsson1998" class="citation journal cs1">Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO (1998). "A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride". <i>Clin. Pharmacol. Ther</i>. <b>64</b> (6): 636–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0009-9236%2898%2990054-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0009-9236%2898%2990054-6'" tppabs="https://doi.org/10.1016%2FS0009-9236%2898%2990054-6" class="external text external">10.1016/S0009-9236(98)90054-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9871428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9871428'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9871428" class="external text external">9871428</a>.</cite></span></li><li id="cite_note-KeserüSwinney2015-44"> <span id="mw-reference-text-cite_note-KeserüSwinney2015-44" class="mw-reference-text"><cite id="CITEREFGyörgy_KeserüDavid_C._Swinney2015" class="citation book cs1">György Keserü; David C. Swinney (28 July 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=7WpICgAAQBAJ&pg=PA165  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=7WpICgAAQBAJ&pg=PA165'" tppabs="https://books.google.com/books?id=7WpICgAAQBAJ&pg=PA165" class="external text external"><i>Thermodynamics and Kinetics of Drug Binding</i></a>. Wiley. pp.<span>&nbsp;</span>165–. ISBN<span>&nbsp;</span><bdi>978-3-527-67304-9</bdi>.</cite></span></li><li id="cite_note-HeesakkersChapple2016-45"> <span id="mw-reference-text-cite_note-HeesakkersChapple2016-45" class="mw-reference-text"><cite id="CITEREFJohn_HeesakkersChristopher_ChappleDirk_De_RidderFawzy_Farag2016" class="citation book cs1">John Heesakkers; Christopher Chapple; Dirk De Ridder; Fawzy Farag (24 February 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=aWKhCwAAQBAJ&pg=PA280  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=aWKhCwAAQBAJ&pg=PA280'" tppabs="https://books.google.com/books?id=aWKhCwAAQBAJ&pg=PA280" class="external text external"><i>Practical Functional Urology</i></a>. Springer. pp.<span>&nbsp;</span>280–. ISBN<span>&nbsp;</span><bdi>978-3-319-25430-2</bdi>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFTraishKrakowskyDorosMorgentaler2019" class="citation journal cs1">Traish, Abdulmaged M.; Krakowsky, Yonah; Doros, Gheorghe; Morgentaler, Abraham (2019). <a href="javascript:if(confirm('https://doi.org/10.1016/j.sxmr.2018.06.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.sxmr.2018.06.002'" tppabs="https://doi.org/10.1016/j.sxmr.2018.06.002" class="external text external">"Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results"</a>. <i>Sexual Medicine Reviews</i>. <b>7</b> (1): 95–114. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.sxmr.2018.06.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.sxmr.2018.06.002'" tppabs="https://doi.org/10.1016%2Fj.sxmr.2018.06.002" class="external text external">10.1016/j.sxmr.2018.06.002</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2050-0521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2050-0521'" tppabs="https://www.worldcat.org/issn/2050-0521" class="external text external">2050-0521</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30098986  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30098986'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30098986" class="external text external">30098986</a>.</cite></span></li><li id="cite_note-pmid24955220-47"> <span id="mw-reference-text-cite_note-pmid24955220-47" class="mw-reference-text"><cite id="CITEREFTraishMulgaonkarGiordano2014" class="citation journal cs1">Traish AM, Mulgaonkar A, Giordano N (2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064044'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064044" class="external text external">"The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression"</a>. <i>Korean J Urol</i>. <b>55</b> (6): 367–79. doi:<a href="javascript:if(confirm('https://doi.org/10.4111%2Fkju.2014.55.6.367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4111%2Fkju.2014.55.6.367'" tppabs="https://doi.org/10.4111%2Fkju.2014.55.6.367" class="external text external">10.4111/kju.2014.55.6.367</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064044'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064044" class="external text external">4064044</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24955220  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24955220'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24955220" class="external text external">24955220</a>.</cite></span></li><li id="cite_note-Weizman2008-48"> <span id="mw-reference-text-cite_note-Weizman2008-48" class="mw-reference-text"><cite id="CITEREFAbraham_Weizman2008" class="citation book cs1">Abraham Weizman (1 February 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=uABKkFdPjhkC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=uABKkFdPjhkC'" tppabs="https://books.google.com/books?id=uABKkFdPjhkC" class="external text external"><i>Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment</i></a>. Springer Science &amp; Business Media. ISBN<span>&nbsp;</span><bdi>978-1-4020-6854-6</bdi>.</cite></span></li><li id="cite_note-TvrdeićPoljak2016-49"> <span id="mw-reference-text-cite_note-TvrdeićPoljak2016-49" class="mw-reference-text"><cite id="CITEREFTvrdeićPoljak2016" class="citation journal cs1">Tvrdeić, Ante; Poljak, Ljiljana (2016). <a href="javascript:if(confirm('https://doi.org/10.21040/eom/2016.2.7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.21040/eom/2016.2.7'" tppabs="https://doi.org/10.21040/eom/2016.2.7" class="external text external">"Neurosteroids, GABAA receptors and neurosteroid based drugs: are we witnessing the dawn of the new psychiatric drugs?"</a>. <i>Endocrine Oncology and Metabolism</i>. <b>2</b> (1): 60–71. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.21040%2Feom%2F2016.2.7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.21040%2Feom%2F2016.2.7'" tppabs="https://doi.org/10.21040%2Feom%2F2016.2.7" class="external text external">10.21040/eom/2016.2.7</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1849-8922  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1849-8922'" tppabs="https://www.worldcat.org/issn/1849-8922" class="external text external">1849-8922</a>.</cite></span></li><li id="cite_note-LemkeWilliams2012-50"> <span id="mw-reference-text-cite_note-LemkeWilliams2012-50" class="mw-reference-text"><cite id="CITEREFThomas_L._LemkeDavid_A._Williams2012" class="citation book cs1">Thomas L. Lemke; David A. Williams (24 January 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA1381  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA1381'" tppabs="https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA1381" class="external text external"><i>Foye's Principles of Medicinal Chemistry</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>1381–. ISBN<span>&nbsp;</span><bdi>978-1-60913-345-0</bdi>.</cite></span></li><li id="cite_note-Ravina2011-51"> <span id="mw-reference-text-cite_note-Ravina2011-51" class="mw-reference-text"><cite id="CITEREFEnrique_Ravina2011" class="citation book cs1">Enrique Ravina (11 January 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA183  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA183'" tppabs="https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA183" class="external text external"><i>The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>183–. ISBN<span>&nbsp;</span><bdi>978-3-527-32669-3</bdi>.</cite></span></li><li id="cite_note-Drugs.com-52"> <span id="mw-reference-text-cite_note-Drugs.com-52" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/availability/generic-avodart.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/availability/generic-avodart.html'" tppabs="https://www.drugs.com/availability/generic-avodart.html" class="external text external">"Generic Avodart Availability"</a>. <i>Drugs.com</i>.</cite></span></li><li id="cite_note-Llewellyn2011-53"> <span id="mw-reference-text-cite_note-Llewellyn2011-53" class="mw-reference-text"><cite id="CITEREFWilliam_Llewellyn2011" class="citation book cs1">William Llewellyn (2011). <a href="javascript:if(confirm('https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971'" tppabs="https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971" class="external text external"><i>Anabolics</i></a>. Molecular Nutrition Llc. pp.<span>&nbsp;</span>968–, 971–. ISBN<span>&nbsp;</span><bdi>978-0-9828280-1-4</bdi>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFMacDonald" class="citation web cs1">MacDonald, Gareth. <a href="javascript:if(confirm('http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt'" tppabs="http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt" class="external text external">"GSK Japan delays alopecia drug launch after Catalent manufacturing halt"</a>.</cite></span></li><li id="cite_note-Drugs.com-2-55"> <span id="mw-reference-text-cite_note-Drugs.com-2-55" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/dutasteride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/dutasteride.html'" tppabs="https://www.drugs.com/international/dutasteride.html" class="external text external">"Dutasteride"</a>. <i>Drugs.com</i>.</cite></span></li><li id="cite_note-pmid16844453-56"> <span id="mw-reference-text-cite_note-pmid16844453-56" class="mw-reference-text"><cite id="CITEREFMerrickButlerWallnerGalbreath2006" class="citation journal cs1">Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Kurko B (2006). "Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy". <i>Urology</i>. <b>68</b> (1): 116–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.urology.2006.01.061  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.urology.2006.01.061'" tppabs="https://doi.org/10.1016%2Fj.urology.2006.01.061" class="external text external">10.1016/j.urology.2006.01.061</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16844453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16844453'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16844453" class="external text external">16844453</a>.</cite></span></li><li id="cite_note-pmid19796455-57"> <span id="mw-reference-text-cite_note-pmid19796455-57" class="mw-reference-text"><cite id="CITEREFSartorGomellaGagnierMelich2009" class="citation journal cs1">Sartor O, Gomella LG, Gagnier P, Melich K, Dann R (2009). "Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design". <i>The Canadian Journal of Urology</i>. <b>16</b> (5): 4806–12. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19796455  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19796455'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19796455" class="external text external">19796455</a>.</cite></span></li><li id="cite_note-pmid26048455-58"> <span id="mw-reference-text-cite_note-pmid26048455-58" class="mw-reference-text"><cite id="CITEREFChuSartorGomellaRudo2015" class="citation journal cs1">Chu FM, Sartor O, Gomella L, Rudo T, Somerville MC, Hereghty B, Manyak MJ (2015). "A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer". <i>European Journal of Cancer</i>. <b>51</b> (12): 1555–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejca.2015.04.028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejca.2015.04.028'" tppabs="https://doi.org/10.1016%2Fj.ejca.2015.04.028" class="external text external">10.1016/j.ejca.2015.04.028</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26048455  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26048455'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26048455" class="external text external">26048455</a>.</cite></span></li><li id="cite_note-pmid26702991-59"> <span id="mw-reference-text-cite_note-pmid26702991-59" class="mw-reference-text"><cite id="CITEREFGaudetVigneaultFosterMeyer2016" class="citation journal cs1">Gaudet M, Vigneault É, Foster W, Meyer F, Martin AG (2016). "Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer". <i>Radiotherapy and Oncology<span>&nbsp;</span>: Journal of the European Society for Therapeutic Radiology and Oncology</i>. <b>118</b> (1): 141–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.radonc.2015.11.022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.radonc.2015.11.022'" tppabs="https://doi.org/10.1016%2Fj.radonc.2015.11.022" class="external text external">10.1016/j.radonc.2015.11.022</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26702991  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26702991'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26702991" class="external text external">26702991</a>.</cite></span></li><li id="cite_note-pmid27330919-60"> <span id="mw-reference-text-cite_note-pmid27330919-60" class="mw-reference-text"><cite id="CITEREFDijkstraWitjesRoosVijverberg2016" class="citation journal cs1">Dijkstra S, Witjes WP, Roos EP, Vijverberg PL, Geboers AD, Bruins JL, Smits GA, Vergunst H, Mulders PF (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485" class="external text external">"The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis"</a>. <i>SpringerPlus</i>. <b>5</b>: 653. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2Fs40064-016-2280-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fs40064-016-2280-8'" tppabs="https://doi.org/10.1186%2Fs40064-016-2280-8" class="external text external">10.1186/s40064-016-2280-8</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485" class="external text external">4870485</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27330919  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27330919'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27330919" class="external text external">27330919</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFFrye2006" class="citation journal cs1">Frye, S. (2006). "Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor". <i>Current Topics in Medicinal Chemistry</i>. <b>6</b> (5): 405–21. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F156802606776743101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F156802606776743101'" tppabs="https://doi.org/10.2174%2F156802606776743101" class="external text external">10.2174/156802606776743101</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16719800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16719800'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16719800" class="external text external">16719800</a>.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/dutasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/dutasteride'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/dutasteride" class="external text external">"Dutasteride"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Androgens_and_antiandrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgens_and_antiandrogens" style="font-size:114%;margin:0 4em">Androgens and antiandrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Androgens<br>(incl. <abbr>AAS</abbr>)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><abbr>AR</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> Androstenediol dipropionate</li>
<li>Boldenone undecylenate</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a></li>
<li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li>
<li>Cloxotestosterone acetate</li>
<li>Prasterone (dehydroepiandrosterone, DHEA)</li>
<li>Prasterone enanthate (DHEA enanthate)</li>
<li>Prasterone sulfate (DHEA sulfate)</li>
<li>Quinbolone</li>
<li>Testosterone<sup>#</sup></li>
<li>Testosterone esters (e.g., testosterone cypionate, testosterone enanthate, testosterone propionate, testosterone undecanoate, testosterone ester mixtures (Deposterona, Omnadren, Sustanon, Testoviron Depot))</li></ul>

<ul><li><i>Dihydrotestosterone derivatives:</i> Androstanolone (stanolone, dihydrotestosterone, DHT)</li>
<li>Androstanolone esters</li>
<li>Bolazine capronate</li>
<li>Drostanolone propionate (dromostanolone propionate)</li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a></li>
<li>Metenolone acetate (methenolone acetate)</li>
<li>Metenolone enanthate (methenolone enanthate)</li>
<li>Stenbolone acetate</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> Bolandiol dipropionate</li>
<li>Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)</li>
<li>Norclostebol</li>
<li>Norclostebol acetate</li>
<li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li>
<li>Trenbolone acetate</li>
<li>Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Metandienone (methandienone, methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)</li>
<li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a></li>
<li>Methyltestosterone 3-hexyl ether</li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone (thiomesterone)</li></ul>

<ul><li><i>17α-Alkylated dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Mibolerone</li>
<li>Norethandrolone</li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li>Propetandrol (propethandrol)</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li>Progestins (e.g., <a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">ethisterone (ethynyltestosterone)</a>, <a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a>, <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">norgestrel</a>, <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone (norethindrone)</a>, lynestrenol, norgestrienone)</li>
<li>Tibolone</li></ul>

<ul><li><i>Progesterone derivatives:</i> <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiestrogens (e.g., <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a>)</li>
<li>GnRH agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>, <a href="Human_chorionic_gonadotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin"><abbr>hCG</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiandrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><abbr>AR</abbr> antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Abiraterone acetate</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone acetate</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Nomegestrol acetate</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Apalutamide</li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Darolutamide</li>
<li>Enzalutamide</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li>Seviteronel<sup>†</sup></li>
<li>Topilutamide (fluridil)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Steroidogenesis<br>inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5α-Reductase</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li>Epristeride</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Saw palmetto extract</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abiraterone acetate</li>
<li><a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li>Bifluranol</li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li>Seviteronel<sup>†</sup></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., bifluranol, <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>, estradiol esters, ethinylestradiol, ethinylestradiol sulfonate, paroxypropione)</li>
<li>GnRH agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>GnRH antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>)</li>
<li>Progestogens (incl., chlormadinone acetate, cyproterone acetate, hydroxyprogesterone caproate, gestonorone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Androgen receptor modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of androgens/anabolic steroids</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="font-size:114%;margin:0 4em">Drugs used in benign prostatic hyperplasia (G04C)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">5α-Reductase inhibitors</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li>Epristeride</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alpha-1 blockers</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alfuzosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfuzosin" title="Alfuzosin">Alfuzosin</a></li>
<li><a href="Doxazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxazosin" title="Doxazosin">Doxazosin</a></li>
<li>Silodosin</li>
<li><a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">Tamsulosin</a></li>
<li><a href="Terazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Terazosin" title="Terazosin">Terazosin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Steroidal antiandrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Delmadinone acetate</li>
<li>Gestonorone caproate</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Herbal products</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Pygeum africanum</i></li>
<li><i>Saw palmetto extract</i></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Mepartricin</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Other_dermatological_preparations_(D11)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Other_dermatological_preparations_(D11)" style="font-size:114%;margin:0 4em">Other dermatological preparations (D11)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-seborrheics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li>
<li><i>Antifungals</i>
<ul><li><a href="Bifonazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Bifonazole" title="Bifonazole">Bifonazole</a></li>
<li>Cetrimonium bromide (cetrimide)</li>
<li>Ciclopirox olamine (ciclopirox)</li>
<li>Climbazole</li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Miconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Miconazole" title="Miconazole">Miconazole</a></li>
<li>Piroctone olamine</li>
<li><a href="Selenium_disulfide.htm" tppabs="https://ptable.com/wiki/compounds/A/Selenium_disulfide" title="Selenium disulfide">Selenium disulfide (selenium sulfide)</a></li>
<li><span class="new">Xenysalate</span></li>
<li><a href="Zinc_pyrithione.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc_pyrithione" title="Zinc pyrithione">Zinc pyrithione (pyrithione zinc)</a></li></ul></li>
<li><i>Antihistamines</i></li>
<li><i>Calcineurin inhibitors</i>
<ul><li><a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosporin" title="Cyclosporin" class="mw-redirect">Cyclosporin</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li><i>Keratolytics</i>
<ul><li>Coal tar</li>
<li><a href="Resorcinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Resorcinol" title="Resorcinol">Resorcinol</a></li>
<li><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylic acid</a></li>
<li><a href="Sulfur.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfur" title="Sulfur">Sulfur</a></li>
<li><a href="Urea.htm" tppabs="https://ptable.com/wiki/compounds/A/Urea" title="Urea">Urea</a> (urea-containing cream)</li></ul></li>
<li><i>Lithium salts</i>
<ul><li>Lithium gluconate</li>
<li>Lithium succinate</li></ul></li>
<li><i>Topical corticosteroids</i> (e.g., hydrocortisone)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Skin lightening</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Hydroquinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroquinone" title="Hydroquinone">Hydroquinone</a></li>
<li><a href="Mequinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mequinol" title="Mequinol">Mequinol</a></li>
<li><a href="Monobenzone.htm" tppabs="https://ptable.com/wiki/compounds/A/Monobenzone" title="Monobenzone">Monobenzone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Skin darkening</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Afamelanotide</li>
<li>Melanotan II</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-inflammatories</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Oxaceprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaceprol" title="Oxaceprol">Oxaceprol</a></li>
<li><a href="Gamma-Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Linolenic_acid" title="Gamma-Linolenic acid">Gamolenic acid</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><i>Topical corticosteroids</i> (e.g., hydrocortisone)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alopecia treatments</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>5α-Reductase inhibitors</i> 
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Saw palmetto extract</li></ul></li>
<li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Topilutamide (fluridil)</li></ul></li>
<li><i>Potassium channel openers</i>
<ul><li><a href="Minoxidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Minoxidil" title="Minoxidil">Minoxidil</a></li></ul></li>
<li><i>Others</i>
<ul><li>Nepidermin</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hair growth inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>5α-Reductase inhibitors</i>
<ul><li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li></ul></li>
<li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li>
<li><a href="Eflornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eflornithine" title="Eflornithine">Eflornithine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens (e.g., testosterone)</li>
<li><a href="Brimonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brimonidine" title="Brimonidine">Brimonidine</a></li>
<li><a href="Calcium_gluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium_gluconate" title="Calcium gluconate">Calcium gluconate</a></li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>)</li>
<li>Hyaluronic acid</li>
<li><a href="Magnesium_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium_sulfate" title="Magnesium sulfate">Magnesium sulfate</a></li>
<li>Pregnenolone acetate</li>
<li>Progestogens (e.g., progesterone)</li>
<li><a href="Povidone-iodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Povidone-iodine" title="Povidone-iodine">Povidone-iodine</a></li>
<li>Tiratricol</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="GlaxoSmithKline" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="GlaxoSmithKline" style="font-size:114%;margin:0 4em">GlaxoSmithKline</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Subsidiaries</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>GlaxoSmithKline Pakistan</li>
<li>GlaxoSmithKline Pharmaceuticals Ltd</li>
<li>Stiefel Laboratories</li>
<li>Tesaro</li>
<li>ViiV Healthcare (85%)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Predecessors,<br>acquisitions</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Allen &amp; Hanburys</li>
<li>Beecham Group</li>
<li>Block Drug</li>
<li>Burroughs Wellcome</li>
<li>Glaxo</li>
<li>Glaxo Wellcome</li>
<li>Human Genome Sciences</li>
<li>Recherche et Industrie Thérapeutiques</li>
<li>Reliant Pharmaceuticals</li>
<li>S. E. Massengill Company</li>
<li>SmithKline Beecham</li>
<li>Smith, Kline &amp; French</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Current</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Pharma</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Advair</li>
<li><a href="Orlistat.htm" tppabs="https://ptable.com/wiki/compounds/A/Orlistat" title="Orlistat">Alli</a></li>
<li>Augmentin</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Rosiglitazone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Rosiglitazone'" tppabs="https://ptable.com/wiki/compounds/A/Rosiglitazone" title="Rosiglitazone">Avandia</a></li>
<li>Beconase</li>
<li><a href="Ibandronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibandronic_acid" title="Ibandronic acid">Boniva</a></li>
<li><a href="Fluticasone_propionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluticasone_propionate" title="Fluticasone propionate">Flixonase</a></li>
<li>Hycamtin</li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamictal</a></li>
<li><a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">Paxil/Seroxat</a></li>
<li>Serlipet</li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Tagamet</a></li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Ventolin</a></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Wellbutrin/Zyban</a></li>
<li><a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">Zantac</a> … <b>more</b></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vaccines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Hepatyrix</li>
<li>Pandemrix</li>
<li>Twinrix</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aquafresh</li>
<li>Horlicks</li>
<li>Nicoderm</li>
<li>Nicorette</li>
<li>NiQuitin</li>
<li>Sensodyne</li>
<li>Tums … <b>more</b></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Former</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>BC Powder</li>
<li>Geritol</li>
<li>Goody's Powder</li>
<li>Lucozade</li>
<li>Ribena</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Board of <br>Directors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Philip Hampton</li>
<li>Emma Walmsley</li>
<li>Simon Dingemans</li>
<li>Roy M. Anderson</li>
<li>Manvinder Banga </li>
<li>Patrick Vallance</li>
<li>Vivienne Cox</li>
<li>Lynn Elsenhans</li>
<li>Jesse Goodman</li>
<li>Judy Lewent</li>
<li>Urs Rohner</li>
<li>Laurie Glimcher</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Thomas Beecham</li>
<li>Silas M. Burroughs</li>
<li>Mahlon Kline</li>
<li>John K. Smith</li>
<li>Henry Wellcome</li>
<li>Andrew Witty</li>
<li>Chris Gent</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Litigation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Canada v. GlaxoSmithKline Inc.</i></li>
<li><i>Christopher v. SmithKline Beecham Corp.</i></li>
<li><i>GlaxoSmithKline Services Unlimited v Commission</i></li>
<li><i>United States v. Glaxo Group Ltd.</i></li>
<li><i>United States v. GlaxoSmithKline</i></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Drug Industry Documents Archive</li>
<li>GlaxoSmithKline Prize</li>
<li><i>Side Effects</i></li>
<li>Study 329</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><figure-inline><span><img src="../I/m/Folder_Hexagonal_Icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Folder_Hexagonal_Icon.svg.png" data-file-width="36" data-file-height="31" data-file-type="drawing" height="14" width="16"></span></figure-inline> <b>Category</b></li></ul>
</div></td></tr></tbody></table></div>













<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>